Avalon Pharmaceuticals to Present at Piper Jaffray Health Care Conference

GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that Kenneth C. Carter, Ph.D., President and CEO, is scheduled to provide an update on the Company at the Piper Jaffray Health Care Conference.
MORE ON THIS TOPIC